Revlon Reaches Deal to Avoid Bankruptcy 
 

The cosmetics company said it has obtained adequate support from bondholders to avert a bankruptcy filing.


 
Cellnex to Buy CK Hutchison's European Tower Businesses in $11.8B Deal 
 

Cellnex Telecom said that it has reached an agreement to acquire CK Hutchison's European tower businesses and assets for an initial investment of about 10 billion euros.


 
Boeing Forecasts Strong China Demand 
 

Boeing Co. on Thursday released strong forecasts for China's aircraft demand, even as the aerospace company said it expects a weaker global market amid the coronavirus pandemic.


 
Tencent's Beijing Boss Battle Could Be Costly 
 

The world's largest game company had another strong quarter, but a darkening regulatory picture could mean tougher times ahead.


 
Nissan Is an Unlikely Pandemic Winner 
 

The pandemic has been surprisingly helpful to the turnarounds underway at Nissan and its French alliance partner Renault.


 
Siemens Profit Beats Expectations 
 

Siemens' industrial profit margin for the fourth quarter came in at 18.7%, while its net profit topped forecasts at EUR1.76 billion, as the engineer


 
Generali Posts Operating Profit Rise 
 

Generali posted a 2.3% rise in 9-month operating profit, as a strong performance in its asset-management business and property and casualty operations offset a decline in the life segment, but its net profit fell 40% on impairments.


 
Tencent's Net Profit Surges on Strength in Online-Game Segment 
 

Tencent Holdings Ltd. said its third-quarter net profit surged 89%, thanks to continued strength in its gaming revenue and better cost efficiency.


 
Scanwell Aims to Offer Instant At-Home Covid Antibody Test 
 

Startup seeks FDA approval for an antibody test which it hopes will allow people to easily stay abreast of their immunity. The company is also readying an at-home antigen test as well as one for chronic kidney disease.


 
Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale 
 

The timing this week of Albert Bourla's sale of about $5.6 million in company shares-on the same day it announced positive results from its Covid-19 vaccine-is drawing scrutiny from some investors.

(END) Dow Jones Newswires

11-12-20 1115ET